0001179110-17-010770.txt : 20170728
0001179110-17-010770.hdr.sgml : 20170728
20170728160428
ACCESSION NUMBER: 0001179110-17-010770
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170727
FILED AS OF DATE: 20170728
DATE AS OF CHANGE: 20170728
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KISHBAUCH MICHAEL D
CENTRAL INDEX KEY: 0001076979
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 17990011
MAIL ADDRESS:
STREET 1: 18 CHERRYVILLE RD
CITY: FLEMINGTON
STATE: NJ
ZIP: 08822
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2017-07-27
0
0001454789
CATABASIS PHARMACEUTICALS INC
CATB
0001076979
KISHBAUCH MICHAEL D
C/O CATABASIS PHARMACEUTICALS, INC.
ONE KENDALL SQ, BLDG 1400E, STE B14202
CAMBRIDGE
MA
02139
1
0
0
0
Stock Option (right to buy)
1.27
2017-07-27
4
A
0
6500
0
A
2027-07-26
Common Stock
6500
6500
D
This option was granted on July 27, 2017 and is scheduled to vest in full on June 7, 2018.
/s/ Deirdre A. Cunnane as attorney-in-fact for Michael D. Kishbauch
2017-07-28